^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    PredicineATLAS™

    Company:
    Predicine
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    PredicineATLAS™ is 600-gene CLIA-certified, pan-cancer liquid biopsy test for comprehensive variant profiling, TMB & MSI assessment using next generation sequencing.
    Cancer:
    Biliary Tract Cancer, Solid Tumor
    Gene:
    HRD (Homologous Recombination Deficiency), MSI (Microsatellite instability), TMB (Tumor Mutational Burden)
    Method:
    Next-Generation Sequencing (NGS)